Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 15, 2022 Filed Mar 18, 2022 01:30 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantCommon Stock 11,040 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-007183 · doc1.xml · nonDerivative · entry 1

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,976

F1 · price: Restricted stock units granted on March 15, 2022. Price not applicable.

Read SEC document
March 15, 2022 Filed Mar 18, 2022 01:24 UTC
Davis George EricEVP, General Counsel
GrantStock Option (Right to buy Common Stock) · Derivative 26,520 $0.00 Strike: $78.27 $0.00
Disclosure

SEC source: 0001567619-22-007181 · doc1.xml · derivative · entry 4

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,520

Underlying: Common Stock · 26,520 shares

Expires 2032-03-14

F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter.

Read SEC document
March 15, 2022 Filed Mar 18, 2022 01:24 UTC
Davis George EricEVP, General Counsel
Tax withholdingCommon Stock 8,290 $78.27 $648,858.30
Disclosure

SEC source: 0001567619-22-007181 · doc1.xml · nonDerivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,710

Read SEC document
March 15, 2022 Filed Mar 18, 2022 01:24 UTC
Davis George EricEVP, General Counsel
GrantCommon Stock 11,040 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-007181 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,000

F1 · price: Restricted stock units granted on March 15, 2022. Price not applicable.

Read SEC document
March 15, 2022 Filed Mar 18, 2022 01:18 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GrantStock Option (Right to buy Common Stock) · Derivative 58,040 $0.00 Strike: $78.27 $0.00
Disclosure

SEC source: 0001567619-22-007179 · doc1.xml · derivative · entry 5

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,040

Underlying: Common Stock · 58,040 shares

Expires 2032-03-14

F2 · derivative.exercise_date: Option grant vests 12/36th on March 15, 2023 and 1/36th on the 15th day of each month thereafter.

Read SEC document
March 15, 2022 Filed Mar 18, 2022 01:18 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Tax withholdingCommon Stock 38,306 $78.27 $2,998,210.62
Disclosure

SEC source: 0001567619-22-007179 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340,543

Read SEC document
March 15, 2022 Filed Mar 18, 2022 01:18 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GrantCommon Stock 40,280 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-007179 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 378,849

F1 · price: Restricted stock units granted on March 15, 2022. Price not applicable.

Read SEC document
March 15, 2022 Filed Mar 18, 2022 01:11 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantStock Option (Right to buy Common Stock) · Derivative 28,670 $0.00 Strike: $78.27 $0.00
Disclosure

SEC source: 0001567619-22-007177 · doc1.xml · derivative · entry 4

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,670

Underlying: Common Stock · 28,670 shares

Expires 2032-03-14

F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter.

Read SEC document
March 15, 2022 Filed Mar 18, 2022 01:11 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Tax withholdingCommon Stock 8,418 $78.27 $658,876.86
Disclosure

SEC source: 0001567619-22-007177 · doc1.xml · nonDerivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,745

Read SEC document
March 15, 2022 Filed Mar 18, 2022 01:11 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 11,940 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-007177 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,163

F1 · price: Restricted stock units granted on March 15, 2022. Price not applicable.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 00:44 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 15,000 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001567619-22-006946 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 15,000 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 9, 2021.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 00:44 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 15,000 $77.81 $1,167,150.00
Disclosure

SEC source: 0001567619-22-006946 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,569

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 9, 2021.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 00:44 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 15,000 $37.46 $561,900.00
Disclosure

SEC source: 0001567619-22-006946 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 353,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 9, 2021.

Read SEC document
March 10, 2022 Filed Mar 15, 2022 00:44 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 15,000 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001567619-22-006946 · doc1.xml · derivative · entry 6

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 15,000 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 9, 2021.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
March 10, 2022 Filed Mar 15, 2022 00:44 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 15,000 $77.57 $1,163,550.00
Disclosure

SEC source: 0001567619-22-006946 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,569

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 9, 2021.

Read SEC document
March 10, 2022 Filed Mar 15, 2022 00:44 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 15,000 $37.46 $561,900.00
Disclosure

SEC source: 0001567619-22-006946 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 353,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 9, 2021.

Read SEC document
March 08, 2022 Filed Mar 10, 2022 22:38 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 12,840 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-006718 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,323

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return for 2019 through 2021 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 100% vests on March 15, 2022, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

Read SEC document
March 08, 2022 Filed Mar 10, 2022 22:45 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GrantCommon Stock 34,780 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-006720 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,569

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return for 2019 through 2021 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 100% vests on March 15, 2022, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

Read SEC document
March 08, 2022 Filed Mar 10, 2022 22:28 UTC
Davis George EricEVP, General Counsel
GrantCommon Stock 9,370 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-006716 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,960

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return for 2019 through 2021 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 100% vests on March 15, 2022, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

Read SEC document
March 08, 2022 Filed Mar 10, 2022 22:00 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 9,370 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-006713 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,223

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return for 2019 through 2021 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 100% vests on March 15, 2022, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:57 UTC SaleCommon Stock 100 $78.37 $7,837.00
Disclosure

SEC source: 0001567619-22-006092 · doc1.xml · nonDerivative · entry 6

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,639

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:57 UTC SaleCommon Stock 122 $78.36 $9,559.92
Disclosure

SEC source: 0001567619-22-006092 · doc1.xml · nonDerivative · entry 5

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,739

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:57 UTC SaleCommon Stock 100 $78.35 $7,835.20
Disclosure

SEC source: 0001567619-22-006092 · doc1.xml · nonDerivative · entry 4

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,861

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:57 UTC SaleCommon Stock 214 $78.35 $16,766.90
Disclosure

SEC source: 0001567619-22-006092 · doc1.xml · nonDerivative · entry 3

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,961

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:57 UTC SaleCommon Stock 45 $78.34 $3,525.30
Disclosure

SEC source: 0001567619-22-006092 · doc1.xml · nonDerivative · entry 2

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,175

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:57 UTC SaleCommon Stock 5,815 $78.33 $455,488.95
Disclosure

SEC source: 0001567619-22-006092 · doc1.xml · nonDerivative · entry 1

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,220

Read SEC document
February 25, 2022 Filed Mar 1, 2022 02:52 UTC Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 8,500 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001567619-22-005823 · doc1.xml · derivative · entry 2

HERON ELAINE J · CIK 0001235471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,500 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
February 25, 2022 Filed Mar 1, 2022 02:52 UTC Exercise / conversionCommon Stock 8,500 $37.46 $318,410.00
Disclosure

SEC source: 0001567619-22-005823 · doc1.xml · nonDerivative · entry 1

HERON ELAINE J · CIK 0001235471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,588

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 03, 2022 Filed Feb 8, 2022 01:48 UTC
Mueller BrianEVP, Chief Financial Officer
Tax withholdingCommon Stock 1,072 $87.77 $94,089.44
Disclosure

SEC source: 0001567619-22-002765 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,709

Read SEC document
January 14, 2022 Filed Jan 19, 2022 23:34 UTC Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 4,250 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001567619-22-001334 · doc1.xml · derivative · entry 3

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,250

Underlying: Common Stock · 4,250 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on July 29, 2021.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 23:34 UTC SaleCommon Stock 4,250 $87.61 $372,342.50
Disclosure

SEC source: 0001567619-22-001334 · doc1.xml · nonDerivative · entry 2

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,970

F1 · date: Trade made pursuant to a 10b5-1 plan executed on July 29, 2021.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 23:34 UTC Exercise / conversionCommon Stock 4,250 $37.46 $159,205.00
Disclosure

SEC source: 0001567619-22-001334 · doc1.xml · nonDerivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,220

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on July 29, 2021.

Read SEC document
January 13, 2022 Filed Jan 15, 2022 01:45 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001567619-22-001225 · doc1.xml · derivative · entry 8

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 5,000 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 13, 2022 Filed Jan 15, 2022 01:45 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $87.86 $439,300.00
Disclosure

SEC source: 0001567619-22-001225 · doc1.xml · nonDerivative · entry 5

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,789

F1 · date: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

Read SEC document
January 13, 2022 Filed Jan 15, 2022 01:45 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $37.46 $187,300.00
Disclosure

SEC source: 0001567619-22-001225 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,789

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

Read SEC document
January 12, 2022 Filed Jan 15, 2022 01:45 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001567619-22-001225 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 5,000 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 12, 2022 Filed Jan 15, 2022 01:45 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $89.00 $445,000.00
Disclosure

SEC source: 0001567619-22-001225 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,789

F1 · date: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

F2 · date: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 50 shares, with the reporting person's purchase of shares at a price of $78.7700 on September 9, 2021. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

Read SEC document
January 12, 2022 Filed Jan 15, 2022 01:45 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $37.46 $187,300.00
Disclosure

SEC source: 0001567619-22-001225 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,789

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 23:09 UTC
Alles Mark JDirector
GrantCommon Stock 2,300 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-000661 · doc1.xml · nonDerivative · entry 1

Alles Mark J · CIK 0001538897 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,300

F1 · price: Restricted stock units granted on January 3, 2022 represent a pro rata share of the 2021 annual award for independent directors and vest on the date immediately prior to the date of the Company's next regular annual meeting of stockholders, the same vesting date for the 2021 annual award for all other independent directors.

Read SEC document
December 21, 2021 Filed Jan 15, 2022 01:45 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
OtherCommon Stock 100 $89.22 $8,922.46
Disclosure

SEC source: 0001567619-22-001225 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,789

Read SEC document
December 16, 2021 Filed Dec 18, 2021 00:03 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 6,000 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001567619-21-022297 · doc1.xml · derivative · entry 8

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 6,000 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
December 16, 2021 Filed Dec 18, 2021 00:03 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 6,000 $84.68 $508,080.00
Disclosure

SEC source: 0001567619-21-022297 · doc1.xml · nonDerivative · entry 5

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,689

F2 · date: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

Read SEC document
December 16, 2021 Filed Dec 18, 2021 00:03 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 6,000 $37.46 $224,760.00
Disclosure

SEC source: 0001567619-21-022297 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,689

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

Read SEC document
December 15, 2021 Filed Dec 18, 2021 00:03 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 6,000 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001567619-21-022297 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,000

Underlying: Common Stock · 6,000 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
December 15, 2021 Filed Dec 18, 2021 00:03 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 6,000 $82.71 $496,260.00
Disclosure

SEC source: 0001567619-21-022297 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,689

F2 · date: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

Read SEC document
December 15, 2021 Filed Dec 18, 2021 00:03 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 6,000 $37.46 $224,760.00
Disclosure

SEC source: 0001567619-21-022297 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,689

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.

Read SEC document
December 10, 2021 Filed Dec 18, 2021 00:03 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GiftCommon Stock 700 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-022297 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,689

F1 · date: On December 10, 2021 the reporting person gifted 700 shares to an educational institution.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 02:42 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 1,500 $87.22 $130,831.50
Disclosure

SEC source: 0001567619-21-021536 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 304,389

F1 · date: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 50 shares, with the reporting person's purchase of shares at a price of $78.7700 on September 9, 2021. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

Read SEC document
October 29, 2021 Filed Feb 12, 2022 02:51 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantCommon Stock 241 $62.41 $15,040.09
Disclosure

SEC source: 0001567619-22-003787 · doc1.xml · nonDerivative · entry 1

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,936

F1 · date: Represents shares acquired by the reporting person on October 29, 2021, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
October 26, 2021 Filed Oct 28, 2021 23:48 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 2,739 $73.60 $201,590.40
Disclosure

SEC source: 0001567619-21-018936 · doc1.xml · nonDerivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,853

F2 · date: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.